Cite
MLA Citation
A. El-Khoueiry et al.. “A first-in-human phase I study of sEphB4-HSA in patients with advanced solid tumors with expansion at the maximum tolerated dose (MTD) or recommended phase II dose (RP2D).” European journal of cancer, vol. 69, n.d., pp. S11–. http://access.bl.uk/ark:/81055/vdc_100039473315.0x000004